PowerPoint slides
Rights and permissions
About this article
Cite this article
Garber, K. Kinase inhibitors overachieve in CLL. Nat Rev Drug Discov 13, 162–164 (2014). https://doi.org/10.1038/nrd4259
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4259
- Springer Nature Limited
This article is cited by
-
The emerging role of mass spectrometry-based proteomics in drug discovery
Nature Reviews Drug Discovery (2022)
-
Staurosporine: new lease of life for parent compound of today’s novel and highly successful anti-cancer drugs
The Journal of Antibiotics (2018)
-
Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
Journal of Investigative Dermatology (2016)
-
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
Cell Death & Disease (2015)